COMBINING A NOVEL DUAL RAF/MEK INHIBITOR WITH IMMUNOMODULATION TO PROMOTE AN ANTI-TUMOR RESPONSE

被引：0

作者：

Dong, Lauren ^{[1
]}

Choi, Hyejin ^{[1
]}

Budhu, Sadna ^{[1
]}

Schulze, Isabell ^{[1
]}

Mehanna, Nezar ^{[1
]}

Rosen, Neal ^{[1
]}

Merghoub, Taha ^{[1
]}

Wolchok, Jedd ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.604

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

604

引用

页码：A634 / A634

页数：1

共 50 条

[31] Anti-tumor Efficacy Profile of a Novel Dual PI3K/mTOR Inhibitor, DS-7423
Hirota, Y.
Sato, K.
Hama, Y.
Nagashima, Y.
Watanabe, R.
Suzuki, N.
Sugimura, M.
Shiose, Y.
EUROPEAN JOURNAL OF CANCER, 2012, 48 : 110 - 110
[32] Discovery of a novel pan-RAF inhibitor with potent anti-tumor activity in preclinical models of BRAFV600E mutant cancer
Hong, Sung Pyo
Ahn, Soon Kil
LIFE SCIENCES, 2017, 183 : 37 - 44
[33] Anti-tumor activity of ASP3026, - A novel and selective ALK inhibitor -
Kuromitsu, Sadao
Mori, Masamichi
Shimada, Itsuro
Kondoh, Yutaka
Shindoh, Nobuaki
Soga, Takatoshi
Furutani, Takashi
Konagai, Satoshi
Sakagami, Hideki
Nakata, Mari
Ueno, Yoko
Saito, Rika
Sasamata, Masao
Mano, Hiroyuki
Kudou, Masafumi
CANCER RESEARCH, 2011, 71
[34] Enhancing Immunogenicity in Metastatic Melanoma: Adjuvant Therapies to Promote the Anti-Tumor Immune Response
Pelka, Sandra
Guha, Chandan
BIOMEDICINES, 2023, 11 (08)
[35] Combination of the ERK inhibitor GDC-0994 with the MEK inhibitor cobimetinib significantly enhances anti-tumor activity in KRAS and BRAF mutant tumor models
Merchant, M.
Chan, J.
Orr, C.
Cheng, J.
Wang, X.
Hunsaker, T.
Wagle, M. C.
Huang, S. A.
Tremayne, J.
Ngu, H.
Solon, M.
Eastham-Anderson, J.
Koeppen, H.
Friedman, L.
Belvin, M.
Moffat, J.
Junttila, M.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : 124 - 124
[36] Discovery of novel hybrids of mTOR inhibitor and NO donor as potential anti-tumor therapeutics
Gao, Xin
Zhao, Fang
Wang, Yang
Ma, Xiaodong
Chai, Huayi
Han, Jingjing
Fang, Fang
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 91
[37] RADIATION ENHANCES MELANOMA RESPONSE TO IMMUNOTHERAPY AND SYNERGIZES WITH BENZODIAZEPINES TO PROMOTE ANTI-TUMOR ACTIVITY
Krummel, Daniel Pomeranz
Nasti, Tahseen
Izar, Benjamin
Xu, Maxwell
Lowder, Lindsey
Press, Robert
Kaluzova, Milota
Kallay, Laura
Rupji, Manali
Burnham, Andre
Li, Guanguan
Ahmed, Taukir
Rosen, Havi
Connolly, Erin
Keskin, Havva
Ben Thomas, Midhun
Curran, Walter
Kudchadkar, Ragini
Weinberg, Brent
Olson, Jeffrey
Schniederjan, Matthew
Neil, Stewart
Su, Jing
Lawson, David
Cook, James
Jenkins, Andrew
Kowalski, Jeanne
Khan, Mohammad
Sengupta, Soma
NEURO-ONCOLOGY, 2019, 21 : 84 - 84
[38] SC-2882, a novel QPCTL inhibitor, with anti-tumor activity in solid tumor models
Mullenders, Jasper
Scheepstra, Marcel
Faas, Michel R.
Galler, Annette B.
Evers, Bastiaan
Wuerthner, Jens U.
CANCER RESEARCH, 2024, 84 (06)
[39] A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the Development of an Anti-Tumor Immune Response
Touati, Walid
Thi Tran
Seguin, Johanne
Diry, Monique
Flinois, Jean-Pierre
Baillou, Claude
Lescaille, Geraldine
Andre, Francois
Tartour, Eric
Lemoine, Francois M.
Beaune, Philippe
de Waziers, Isabelle
CURRENT GENE THERAPY, 2014, 14 (03) : 236 - 246
[40] Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma
Sun, Mengzhu
Garnier, Laure
Chevalier, Romane
Roumain, Martin
Wang, Chen
Angelillo, Julien
Montorfani, Julien
Pick, Robert
Brighouse, Dale
Fournier, Nadine
Tarussio, David
Tissot, Stephanie
Lobaccaro, Jean-Marc
Petrova, Tatiana V.
Jandus, Camilla
Speiser, Daniel E.
Kopf, Manfred
Pot, Caroline
Scheiermann, Christoph
Homicsko, Krisztian
Muccioli, Giulio G.
Garg, Abhishek D.
Hugues, Stephanie
NATURE COMMUNICATIONS, 2025, 16 (01)

← 1 2 3 4 5 →